FDA Inspection 1210337 — Anipro/Xtraformance Feeds - AL002
The FDA completed an inspection of Anipro/Xtraformance Feeds - AL002 on June 9, 2023 in Cleveland, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 9, 2023
- Fiscal Year
- 2023
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Cleveland, AL (United States)